Eur Rev Med Pharmacol Sci 2017; 21 (6): 1176-1176
DOI:

The study of endogenous hepatocyte growth factor in the pathogenesis of intracranial aneurysms

L.-L. Yu, Y.-J. Liu, Z.-H. Wang, L. Shi, L.-X. Liu

Department of Neurosurgery, Qingdao Hiser Medical Center, Qingdao, Shandong, China

The article “The study of endogenous hepatocyte growth factor in the pathogenesis of intracranial aneurysms” by L.-L. Yu, Y.-J. Liu, Z.-H. Wang, L. Shi, L.-X. Liu, published in Eur Rev Med Pharmacol Sci 2017; 21 (4): 795-803 has been withdrawn.

This article has been withdrawn. The Publisher apologizes for any inconvenience this may cause.

https://www.staging.europeanreview.org/article/12244

Free PDF Download

To cite this article

L.-L. Yu, Y.-J. Liu, Z.-H. Wang, L. Shi, L.-X. Liu
The study of endogenous hepatocyte growth factor in the pathogenesis of intracranial aneurysms

Eur Rev Med Pharmacol Sci
Year: 2017
Vol. 21 - N. 6
Pages: 1176-1176
DOI:

Keywords Related articles:

  1. The study of endogenous hepatocyte growth factor in the pathogenesis of intracranial aneurysms
  2. Expression of miR-146a-5p in patients with intracranial aneurysms and its association with prognosis
  3. Clinical application of solitaire AB stents in the embolization of intracranial aneurysms
  4. In vitro neural differentiation of bone marrow stromal cells induced by hepatocyte growth factor and glial cell derived neurotrophic factor
  5. Gene expression analysis of ruptured and un-ruptured saccular intracranial aneurysm